Williams-Gray, Caroline H., Evans, Jonathan R., Goris, An, Foltynie, Thomas, Ban, Maria, Robbins, Trevor W., ...
Cognitive abnormalities are common in Parkinson's disease, with important social and economic implications. Factors influencing their evolution remain unclear but are crucial to the development of...
Tau and alpha-synuclein in susceptibility to, and dementia in, Parkinson's disease (2007)
Clark, Graeme R, Foltynie, Thomas, Lewis, Simon J. G, Brown, Joanne, ...
Objective: Parkinson's disease (PD) is a neurodegenerative condition that typically presents as a movement disorder but is known to be associated with variable degrees of cognitive impairment...
Foltynie, Thomas, Matthews, Fiona E, Ishihara, Lianna, Brayne, Carol, MRC CFAS
Abstract Background Estimates of the incidence and prevalence of chronic diseases can be made using established cohort studies but these estimates may have lower reliability if based purely on...
No alterations in alpha-synuclein gene dosage observed in sporadic Parkinson's disease (2006)
Foltynie, Thomas, Brown, Joanne, Maranian, Melanie, Walton, Amie, ...
Foltynie, Thomas, Brayne, Carol E. G., Robbins, Trevor W., Barker, Roger A.
We have used multiple sources to identify a population‐representative cohort of newly diagnosed patients with parkinsonism and Parkinson’s disease in the UK over a 2‐year period. All...
Foltynie, Thomas, Brayne, Carol E. G., Robbins, Trevor W., Barker, Roger A.
We have used multiple sources to identify a population-representative cohort of newly diagnosed patients with parkinsonism and Parkinson’s disease in the UK over a 2-year period. All patients have...
Foltynie, Thomas, Brayne, Carol E. G., Robbins, Trevor W., Barker, Roger A.
We have used multiple sources to identify a population-representative cohort of newly diagnosed patients with parkinsonism and Parkinson’s disease in the UK over a 2-year period. All patients have...